Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

BACKGROUND: In the Women’s Health Initiative (WHI) randomized trial, estrogen plus progestin increased both breast cancer incidence and mortality. In contrast, most observational studies associate estrogen plus progestin with favorable prognosis breast cancers. To address differences, a cohort of WH...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Chlebowski, Rowan T., Manson, JoAnn E., Anderson, Garnet L., Cauley, Jane A., Aragaki, Aaron K., Stefanick, Marcia L., Lane, Dorothy S., Johnson, Karen C., Wactawski-Wende, Jean, Chen, Chu, Qi, Lihong, Yasmeen, Shagufta, Newcomb, Polly A., Prentice, Ross L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3691942/
https://ncbi.nlm.nih.gov/pubmed/23543779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt043
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk